Millipore Sigma Vibrant Logo

ABS2114-100UG Anti-Vaccinia related kinase-1 Antibody, C-Terminus

Anti-vaccinia related kinase-1, C-Terminus, Cat. No. ABS2114, is a rabbit polyclonal antibody that detects Serine/threonine-protein kinase VRK1 and has been tested for use in Western Blotting and ChIP-seq.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Research Category: Signaling Gene Symbol: VRK1 UniProt Number: Q99986
View Products on Sigmaaldrich.com
ABS2114-100UG
100 μg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HWB, ChIP-seqRbPurifiedPolyclonal Antibody
      Description
      Catalogue NumberABS2114-100UG
      DescriptionAnti-Vaccinia related kinase-1 Antibody, C-Terminus
      Alternate Names
      • Serine/threonine-protein kinase VRK1
      • EC: 2.7.11.1
      • Vaccinia-related kinase 1
      Background InformationSerine/threonine-protein kinase VRK1 (UniProt: Q99986; also known as EC: 2.7.11.1, Vaccinia-related kinase 1) is encoded by the VRK1 gene (Gene ID: 7443) in human. VRK1 is a serine/threonine kinase that is widely expressed with high expression in fetal liver, testis and thymus. Its protein kinase domain is located in the amino acids 37-317. VRK1 is involved in Golgi disassembly during the cell cycle and Golgi fragmentation. VRK1 phosphorylation by PLK3, which leads to induction of Golgi fragmentation. VRK1 acts by mediating phosphorylation of downstream target protein and is shown to phosphorylate threonine 18 of p53/TP53 and thereby prevent the interaction between p53/TP53 and MDM2. VRK1 is autophosphorylated at various serine and threonine residues, however, it does not impair its ability to phosphorylate p53/TP53. VRK1 is also shown to phosphorylate casein, histone H3, and ATF2, which activates its transcriptional activity. In cancer cell lines VRK1 is reported to phosphorylate histone H2A at threonine 120 that results in inappropriate gene expression, including up-regulation of cyclin D1, which can promote oncogenic transformations. Mutations in VRK1 gene have been linked to Pontocerebellar hypoplasia 1A, a condition characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth. (Ref.: Aihara, H., et al., (2016). Mol. Cell 64(1); 176-188).
      References
      Product Information
      FormatPurified
      PresentationPurified rabbit polyclonal antibody in buffer containing 50 mM KCl, 25 mM HEPES (pH 7.6), 10% glycerol, 0.1 mM EDTA, 0.01% NP40 with 0.05% sodium azide.
      Applications
      ApplicationAnti-vaccinia related kinase-1, C-Terminus, Cat. No. ABS2114, is a rabbit polyclonal antibody that detects Serine/threonine-protein kinase VRK1 and has been tested for use in Western Blotting and ChIP-seq.
      Key Applications
      • Western Blotting
      • ChIP-seq
      Application NotesWestern Blotting Analysis: 2 µg/mL from a representative lot detected Vaccinia related kinase-1, C-Terminus in HT1080 cell lysate.

      ChIP-seq Analysis: A representative lot detected Vaccinia related kinase-1, C-Terminus in HT1080 cells (Aihara, H., et. al. (2016). Mol Cell. 64(1):176-188).

      Western Blotting Analysis: A representative lot detected Vaccinia related kinase-1, C-Terminus in HT1080, MDA-MB-231, AZ521 and Panc1 cells, recombinant hVRK1, hVRK1, immunopurified from HeLa cells, FLAG-tagged hVRK1 expressed in E. coli, Normal blood cells, Primary hepatocytes and intestinal and pancreatic epithelial cell (Aihara, H., et. al. (2016). Mol Cell. 64(1):176-188).

      Western Blotting Analysis: A 1:200 dilution from a representative lot detected Vaccinia related kinase-1, C-Terminus in HeLa cell lysate (Courtesy of Dr. Ito Takashi at Nagasaki University).
      Biological Information
      ImmunogenHis-tagged recombinant fragment corresponding to 128 amino acids from the C-terminal region of human Vaccinia-related kinase-1 (VRK1).
      EpitopeC-terminus
      ConcentrationPlease refer to lot specific datasheet.
      HostRabbit
      SpecificityThis rabbit polyclonal antibody detects Serine/threonine-protein kinase VRK1 in human cells. It targets an epitope within 128 amino acids from the C-terminal region.
      IsotypeIgG
      Species Reactivity
      • Human
      Species Reactivity NoteHuman.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • VRK1
      Purification MethodAffinity Purified
      UniProt Number
      Molecular Weight~47 kDa observed; 45.48 kDa calculated. Uncharacterized bands may be observed in some lysate(s).
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blotting in HeLa cell lysate.

      Western Blotting Analysis: 2 µg/mL of this antibody detected Vaccinia related kinase-1, C-Terminus in HeLa cell lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.

      Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      ABS2114-100UG 04054839460142